Stay updated on Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check5 days agoChange DetectedVersion bumped in the site footer from v3.5.4 to v3.5.5, signaling a new deployment of the ClinicalTrials.gov interface. No user-facing content changes are indicated by this update.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a new build/version of the page's history metadata.SummaryDifference0.1%

- Check40 days agoChange DetectedThe latest revision entry in the record history has been updated to v3.5.3, replacing the prior v3.5.2. This indicates the study record was updated to version v3.5.3.SummaryDifference0.1%

- Check55 days agoChange DetectedNew revision entry v3.5.2 added and v3.5.0 removed from the history.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the Record History.SummaryDifference0.1%

- Check90 days agoChange DetectedThe history shows a new revision v3.4.3 was added and v3.4.2 removed, updating the version history display.SummaryDifference0.1%

Stay in the know with updates to Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.